Structural Basis for T Cell Alloreactivity among Three HLA-B14 and HLA-B27 Antigens

Abstract

The existence of cytotoxic T cells (CTL) cross-reacting with the human major histocompatibility antigens HLA-B14 and HLA-B27 suggests that their alloreactivity could be due to presentation of shared peptides in similar binding modes by these molecules. We therefore determined the crystal structures of the subtypes HLA-B*1402, HLA-B*2705, and HLA-B*2709 in complex with a proven self-ligand, pCatA (peptide with the sequence IRAAPPPLF derived from cathepsin A (residues 2-10)), and of HLA-B*1402 in complex with a viral peptide, pLMP2 (RRRWRRLTV, derived from latent membrane protein 2 (residues 236 -244) of Epstein-Barr virus). Despite the exchange of 18 residues within the binding grooves of HLA-B*1402 and HLA-B*2705 or HLA-B*2709, the pCatA peptide is presented in nearly identical conformations. However, pLMP2 is displayed by HLA-B*1402 in a conformation distinct from those previously found in the two HLA-B27 subtypes. In addition, the complexes of HLA-B*1402 with the two peptides reveal a nonstandard, tetragonal mode of the peptide N terminus anchoring in the binding groove because of the exchange of the common Tyr-171 by His-171 of the HLA-B*1402 heavy chain. This exchange appears also responsible for reduced stability of HLA-B14-peptide complexes in vivo and slow assembly in vitro. The studies with the pCatA peptide uncover that CTL cross-reactive between HLA-B14 and HLA-B27 might primarily recognize the common structural features of the bound peptide, thus neglecting amino acid replacements within the rim of the binding grooves. In contrast, structural alterations between the three complexes with the pLMP2 peptide indicate how heavy chain polymorphisms can influence peptide display and prevent CTL cross-reactivity between HLA-B14 and HLA-B27 antigens.T cells possessing the ability to recognize major histocompatibility complex (MHC) 2 molecules from another individual of the same species, also termed alloreactive T cells, may constitute up to 10% of the T cell pool of an individual, and their precursor frequency can be 100 -1,000-fold higher than that of self-restricted T cells directed against a foreign peptide (1, 2). The ability of alloreactive T cells to cross-react with nonself-MHC molecules is a major obstacle preventing successful organ transplantations (3-5). Two mechanisms, direct or indirect allorecognition, can be responsible for the rejection of a transplant by alloreactive T cells (6). In the first case, donor cells expressing MHC molecules are directly recognized by host T cells (7), whereas indirect allorecognition involves the presentation of peptides derived from donor proteins by MHC molecules of the host, followed by the detection of the complexes by the host T cells (8). However, although alloreactive T cells are very common and of great clinical importance, neither the primary basis for their existence nor the reasons underlying their cross-reactivity are sufficiently understood to draw general conclusions (9 -11). Only very few studies have addressed the structural basis for the recognition...

Constraints within major histocompatibility complex class I restricted peptides: Presentation and consequences for T-cell recognition

“…The fact that prolines apply significant torsional limitations on the peptide backbone makes them an obvious candidate for imposing selfconstraints. The clearest example to date of proline constraints in an MHC-I restricted peptide whose structure has been solved is the 9mer IRAAPPPLF derived from the signal sequence of cathepsin A (34). The frequency of prolines in immunogenic peptides is likely to reflect that certain MHC-I alleles, notably the HLA B7 supertype, exhibit specificity for a P2-Pro anchoring motif.…”

HLA-B*13:01 Is Associated with Salazosulfapyridine-Induced Drug Rash with Eosinophilia and Systemic Symptoms in Chinese Han Population

“…In this procedure, the protein sequences of HLA alleles B*13:01, B*15:05 and B*39:01 were retrieved from the International Immunogenetics (IMGT)/HLA database [17] and their structures were modeled using MODELLER [18,19] from Protein Data Bank IDs 1N2R [20], 1XR8 [21] and 3BVN [22] with 100, 99 and 98% sequence identity, respectively. Then, we generated the structure of SASP using CORINA [23].…”

The Role of HLA-B27 in Spondyloarthritis

“…B*2705 and B*1403 show only 3%-5% peptide sharing 14 . Interestingly, a single peptide, IRAAPPPLF, derived from cathepsin A signal sequence residues 2-10, binds B*2705, B*2709, B*1402, and B*1403, and a crystallographic study of the first 3 alleles (B*1403 crystals could not be obtained) showed that all bind this peptide with the same conformation 15 . This peptide binding evidently might account for the very limited alloreactive cytotoxic T lymphocytes (CTL) cross-reactivity observed among B*2705, B*1402, and B*1403 14 .…”